MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    A pathology-validated study to investigate the role of Uric Acid in Parkinson’s Disease

    P. Pecoraro, S. Carbone, V. Di Lazzaro, L. Di Biase (Rome, Italy)

    Objective: The aim of this study is to compare plasma uric acid levels between pathology-confirmed and clinically misdiagnosed Parkinson’s disease patients at a single-patient level.…
  • 2024 International Congress

    Burden of Movements Disorders at Initiative Plus Center Hospital

    P. Kiatoko, K. Luse (KINSHASA, The Democratic Republic of the Congo)

    Objective: describe the socio-demographic, clinical characteristics and evolutionary profiles of patients followed for movement disorders Background: The DR Congo specialists in abnormal movements are rare,…
  • 2024 International Congress

    Improving awareness of motor fluctuations in Parkinson’s Disease: an educational patient support program using a waist-worn device.

    N. Caballol, A. ávila, A. Planas-Ballvé, A. Peral, J. Hernández-Vara, S. Belmonte, S. Enríquez, S. Sánchez, D. Cerdán, I. Cabo, N. López-Ariztegui, G. Carvalho, JM. Velázquez, T. Delgado, J. Bocos, B. Ruiz, B. Claramonte, J. Herreros-Rodríguez, D. Santos-García, C. Cores-Bartolomé, J. González-Ardura, D. Ceberino, JM. Salom, R. Rashid, A. Méndez, C. Madrid-Navarro, A. Mulet, D. Rodríguez-Martín, I. Pijuan, I. Tegel (Sant Joan Despí, Spain)

    Objective: To describe the utility of an educational patient support program designed to improve awareness of motor fluctuations (MF) and provide education on motor and…
  • 2024 International Congress

    Utility of Serum α-synuclein Seed Amplification Assay as a Parkinson’s Disease Biomarker

    S. Mosovsky, A. Okuzumi, C. Adler, T. Beach, T. Foroud, G. Serrano, J. Eberling, L. Oliveira, T. Hatano, N. Hattori, B. Mollenhauer, L. Chahine (Pittsburgh, USA)

    Objective: To determine the sensitivity and specificity of serum α-synuclein seed amplification assay (SAA) for Parkinson’s disease (PD) diagnosis in the Systemic Synuclein Sampling Study…
  • 2023 International Congress

    A framework to standardize gait study protocols in Parkinson’s disease

    M. Mancini, J. Hausdorff, E. Pelosin, P. Bonato, R. Camicioli, T. Ellis, J. Klucken, L. Gifford, A. Fasano, A. Nieuwboer, K. Kopil, K. Klapper, A. Mirelman (Portland, USA)

    Objective: To provide recommendations for a minimum set of gait outcome measures to be adopted in projects evaluating people with Parkinson’s disease (PD). Background: Gait…
  • 2023 International Congress

    Postoperative change of local field potentials of subthalamic nucleus during and after period of microlesion effect of implantation of deep brain stimulation lead.

    H. Saiki, T. Nakura, S. Taguchi, S. Miyachi, M. Doyu (Nagakute, Japan)

    Objective: To study changes in beta oscillation before and after microlesion effect in deep brain stimulation (DBS) lead implantation. Background: Increased beta oscillation has been…
  • 2023 International Congress

    Inhibition of LRRK2 kinase activity promotes glucocerebrosidase transport to the lysosomes in primary monocyte-derived macrophages from patients with GBA-associated Parkinson’s disease

    K. Basharova, A. Bezrukova, A. Izyumchenko, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: The aim was to evaluate the effectiveness of leucine-rich repeat kinase 2 (LRRK2) kinase activity inhibition in restoring transport of the enzyme glucocerebrosidase (GCase),…
  • 2023 International Congress

    Wavelet-based bracketing, time-frequency beta-burst detection: new insights in Parkinson’s disease

    T. Sil, M. Muthuraman, H. Eldebakey, I. Hanafi, J. Volkmann, M. Reich, R. Peach (Wuerzburg, Germany)

    Objective: To identify bursts in wide frequency bands and show the relation between burst features and clinical scores. Background: Beta burst activity is a pathophysiological…
  • 2023 International Congress

    Exploring patient-physician communication in Parkinson’s disease management: a qualitative analysis

    A. Pilotto, L. Tonges, J. Pagonabarraga (Brescia, Italy)

    Objective: To explore the unmet needs in patient-physician communication from different perspective.To explore the unmet needs in patient-physician communication from different perspective. Background: Patient-physician communication…
  • 2023 International Congress

    Neuroprotective properties of arylpiperazine-sulphonamides in an in vitro model of Parkinson’s disease

    A. Kingslake, V. Soskic, M. Iravani (Hatfield, United Kingdom)

    Objective: To investigate the neuroprotective effects of novel arylpiperazine compounds as measured by viability of SH-SY5Y cells in vitro. Background: Parkinson’s disease (PD) is a…
  • « Previous Page
  • 1
  • …
  • 190
  • 191
  • 192
  • 193
  • 194
  • …
  • 436
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley